Bonus Biogroup (BONS) — Capital Reinvestment Ratio

Latest as of December 2008: 0.76x

Bonus Biogroup (BONS) has a Capital Reinvestment Ratio of 0.76x as of December 2008, meaning it reinvests 1% of its operating cash flow (ILA20.52 Million) in capital expenditures (ILA15.67 Million). Check Bonus Biogroup tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.76x
Capex / Operating Cash Flow

Operating Cash Flow

ILA20.52 Million
ILA

Capital Expenditures

ILA15.67 Million
ILA

Data as of

Dec 2008
Most recent filing

Bonus Biogroup Capital Reinvestment Ratio (2008–2008)

This chart tracks Bonus Biogroup's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see BONS cash flow metrics.

Annual Capital Reinvestment Ratio for Bonus Biogroup (2008–2008)

Year-by-year Capital Reinvestment Ratio for Bonus Biogroup from 2008 to 2008. See Bonus Biogroup free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (ILA) Capital Expenditures YoY Change
2008 0.76x ILA20.52 Million ILA15.67 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow